Could CGRP mAbs for migraine trigger rheumatoid arthritis? Insights from a case report
CGRP mAbs are effective for migraine prevention, but cases of immune-mediated disease flares are documented. This case suggests a possible association between CGRP mAbs and RA onset. Further research is essential to understand the impact of CGRP modulation in autoimmune diseases.
Authors
- Flávio Costa (ORCID: https://orcid.org/0000-0002-8231-7110)
- Catarina Oliveira Silva (ORCID: https://orcid.org/0000-0002-5077-5176)
- T. Meirinhos (ORCID: https://orcid.org/0000-0002-0456-1281)
- Taciana Videira
- Patrícia Pinto (ORCID: https://orcid.org/0000-0001-9197-7586)
- Ana Sofia Pinto
- Tiago Beirão (ORCID: https://orcid.org/0000-0003-1142-4469)
- Beatriz Samões (ORCID: https://orcid.org/0000-0003-3164-0839)
- Catarina Rua (ORCID: https://orcid.org/0000-0002-0404-4399)
- Romana Vieira
- Diogo Fonseca
- Joana Aleixo-Santos
Institutions
- Instituto Superior de Espinho (PT)
Publication Details
- Journal
- ARP Rheumatology
- Published
- 2024-12-31
- DOI
- https://doi.org/10.63032/lzfi4171
- Citations
- 1
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.39